GSK's shares are falling 4% in premarket trading Wednesday after the British pharma giant posted lower-than-estimated quarterly sales and lowered its projection for vaccine sales. The company ...

Let’s dig in. Despite its disappointing share price performance, GSK is still the UK’s eighth-largest listed company. It has a market cap of £58bn and brought in over £30bn in revenue last year.

Drugmaker GSK saw a sharp drop in revenue from its blockbuster ... hit by fewer of the shots being given out in the US. The UK’s second-biggest pharmaceutical firm still saw 2% sales growth ...

Drugmaker GSK saw a sharp drop in revenue from its blockbuster Arexvy vaccine in the third ... hit by fewer of the shots being given out in the US. The UK’s second-biggest pharmaceutical firm still ...

(Alliance News) - GSK PLC on Tuesday said that it has signed a deal to buy CMG1A46 from Chimagen Biosciences for USD300 million upfront. The London-based pharmaceutical and biotechnology firm ...